Thomas A. Mitro

2021

In 2021, Thomas A. Mitro earned a total compensation of $1.7M as Former President and Chief Operating Officer at Aerie Pharmaceuticals, a 8% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$246,056
Option Awards$729,111
Salary$511,020
Stock Awards$246,960
Other$8,846
Total$1,741,993

Mitro received $729.1K in option awards, accounting for 42% of the total pay in 2021.

Mitro also received $246.1K in non-equity incentive plan, $511K in salary, $247K in stock awards and $8.8K in other compensation.

Rankings

In 2021, Thomas A. Mitro's compensation ranked 6,609th out of 12,405 executives tracked by ExecPay. In other words, Mitro earned more than 46.7% of executives.

ClassificationRankingPercentile
All
6,609
out of 12,405
47th
Division
Manufacturing
2,852
out of 5,494
48th
Major group
Chemicals And Allied Products
1,255
out of 2,369
47th
Industry group
Drugs
1,119
out of 2,090
47th
Industry
Biological Products, Except Diagnostic Substances
269
out of 452
41st
Source: SEC filing on April 26, 2022.

Mitro's colleagues

We found seven more compensation records of executives who worked with Thomas A. Mitro at Aerie Pharmaceuticals in 2021.

2021

Vicente Anido

Aerie Pharmaceuticals

Chief Executive Officer

2021

Raj Kannan

Aerie Pharmaceuticals

Chief Executive Officer

2021

Casey Kopczynski

Aerie Pharmaceuticals

Chief Innovation Officer, Head of Research and External Innovation

2021

John LaRocca

Aerie Pharmaceuticals

General Counsel

2021

Benjamin McGraw

Aerie Pharmaceuticals

Former Interim Executive Chair

2021

Richard Rubino

Aerie Pharmaceuticals

Chief Financial Officer

2021

Christopher Staten

Aerie Pharmaceuticals

Chief Financial Officer

News

You may also like